UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth

Molecular cancer therapeutics, 2017-08, Vol.16 (8), p.1680-1692

2017

Volltextzugriff (PDF)

Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function

Infection and immunity, 2014-07, Vol.82 (7), p.2802-2814

2014

Volltextzugriff (PDF)

Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes

Cancer immunology research, 2018-01, Vol.6 (1), p.59-68

2018

Volltextzugriff (PDF)

Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors

Molecular cancer research, 2019-01, Vol.17 (1), p.70-83

2019

Volltextzugriff (PDF)

Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate Cancer

Molecular cancer therapeutics, 2024-04, Vol.23 (4), p.552

2024

Volltextzugriff (PDF)

Conceptual barriers to understanding physical barriers

Seminars in cell & developmental biology, 2015-06, Vol.42, p.13-21

2015

Volltextzugriff (PDF)

RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer

Inflammatory bowel diseases, 2013-05, Vol.19 (6), p.1295-1305

2013

Volltextzugriff (PDF)

Abstract 944: Glucocorticoid receptor (GR)-mediated activation of cyclic-adenosine monophosphate (cAMP) pathway gene expression following androgen receptor (AR) antagonism of prostate cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.944-944

2018

Volltextzugriff (PDF)

Abstract B017: A soluble form of CD80 inhibits PD-L1 immune suppression and stimulates T cells through CD28-specific pathways indicating potential for increased therapeutic activity over checkpoint inhibition alone

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B017-B017

2016

Volltextzugriff (PDF)

Abstract 2863: RNase-L modulates the immune response to intestinal damage and ameliorates murine colitis and colitis-associated cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2863-2863

2013

Volltextzugriff (PDF)

The diagnostic and prognostic role of cytokines in colon cancer

Gastrointestinal cancer, 2011-04, Vol.1, p.27

2011

Volltextzugriff (PDF)

The Role of RNase-L in Intestinal Homeostasis and Disease

Long, Tiha M

2014

Volltextzugriff (PDF)

Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid‐derived suppressor cells

Journal of leukocyte biology, 2018-03, Vol.103 (3), p.395-407

2018

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(12)
Dissertationen
(1)

Sprache

Englisch
(13)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth

Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function

Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes

Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors

Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate Cancer

Conceptual barriers to understanding physical barriers

RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer

Abstract 944: Glucocorticoid receptor (GR)-mediated activation of cyclic-adenosine monophosphate (cAMP) pathway gene expression following androgen receptor (AR) antagonism of prostate cancer

Abstract B017: A soluble form of CD80 inhibits PD-L1 immune suppression and stimulates T cells through CD28-specific pathways indicating potential for increased therapeutic activity over checkpoint inhibition alone

Abstract 2863: RNase-L modulates the immune response to intestinal damage and ameliorates murine colitis and colitis-associated cancer

The diagnostic and prognostic role of cytokines in colon cancer

The Role of RNase-L in Intestinal Homeostasis and Disease

Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid‐derived suppressor cells

Suchergebnisse filtern